Reasons to subscribe
Get essential regular industry updates
Receive free market and regulatory data
Don't miss product announcements and exclusive offers
- 4 Get trusted, reliable and accurate information for your business
CBD-Intel provides impartial, independent and premium market and regulatory analysis for the cannabidiol (CBD) sector worldwide. We will keep you updated with news, free content, events, exclusive offers and much more!
CBD-Intel provides premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide.
We provide our clients with the tools to navigate this fast-moving sector, tailor their business strategy, optimise resources and make informed decisions. We offer a wide range of services from long term subscription plans, individual reports available for purchase, customised research and consultancy support.
Get valuable insights on the international market landscape for CBD including market trends, product categories, key players, detailed pricing and competitor analysis.
Reduce business risks by keeping up with product-specific legal requirements and regulatory obligations across international jurisdictions.
Understand how the development of CBD markets globally and the impact of market and regulatory changes may affect your business to optimise your company strategy.
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Check out our new regulatory data on medical and recreational cannabis in 54 jurisdictions around the world
The report, accompanied by a more detailed database, provides an overview of the regulatory situation in the selected countries, using maps, and assesses the likelihood that the status quo may change in the future.
Available for purchase
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.